Mirror Biologics, Inc.
Clinical trials sponsored by Mirror Biologics, Inc., explained in plain language.
-
New immune therapy trial offers hope for advanced liver cancer patients
Disease control TerminatedThis study tests whether an immunotherapy called AlloStim can help people with advanced liver cancer live longer and feel better than current standard treatments. The trial involves 150 Asian adults with advanced liver cancer who haven't had previous treatment for their advanced …
Phase: PHASE2, PHASE3 • Sponsor: Mirror Biologics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New combo therapy aims to reawaken immune system against tough colon cancers
Disease control TerminatedThis study aimed to test whether a two-part experimental immunotherapy could help control advanced colorectal cancer that had stopped responding to all standard treatments. It was designed for patients whose cancer had spread and who had already tried and failed at least three pr…
Phase: PHASE2 • Sponsor: Mirror Biologics, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC